Indeed, preliminary data from our laboratory clearly indicate that as a function of diabetes, guanfacine suppresses the increase in mRNA expression of TRPV1 and TRPA1 in several regions of the central nervous system including pons, LSSC, and DRG (unpublished data). Here, TRPA1 is linked to diabetes mellitus.